Revolution Medicines, Inc. (RVMDW) Total liabilities 2019–2025
Revolution Medicines, Inc. (RVMDW) total liabilities at each fiscal year-end, per SEC filings.
$723.2MFY2025 · since FY2019: $68.0M → $723.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $723.2M | +146.7% |
| FY2024 | $293.1M | +24.5% |
| FY2023 | $235.5M | +85.8% |
| FY2022 | $126.7M | -6.4% |
| FY2021 | $135.4M | +46.0% |
| FY2020 | $92.7M | +36.4% |
| FY2019 | $68.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Shareholders’ equityRVMDW overview →